We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 10,000 results
  1. Mitochondrial targeted antioxidants as potential therapy for huntington’s disease

    Huntington’s disease (HD) is an inherited neurodegenerative disorder caused by an expansion in CAG repeat on huntington (Htt) gene, leading to a...

    Shubham Upadhayay, Puneet Kumar in Pharmacological Reports
    Article 09 July 2024
  2. Insulin resistance, clinical presentation and resistance to selective serotonin and noradrenaline reuptake inhibitors in major depressive disorder

    Background

    The understanding of mechanisms underlying non-response to antidepressants is limited. The latest data highlights the role of insulin...

    Anna J. Krupa, Adrian A. Chrobak, ... Marcin Siwek in Pharmacological Reports
    Article Open access 09 July 2024
  3. Take an individualized approach when managing women of reproductive age with uterine fibroids

    Uterine fibroids are the most common gynaecological tumour in women of reproductive age and can cause heavy menstrual bleeding, anaemia, pelvic pain,...

    Sheridan M. Hoy in Drugs & Therapy Perspectives
    Article 09 July 2024
  4. Medication errors in older patients: a pharmacovigilance perspective

    Introduction

    Drug regulatory agencies are particularly interested in pharmacovigilance data relating to medication errors (MEs) involving a...

    Marie-Laure Laroche, Michel Guillaumin, ... Marie-Blanche Valnet-Rabier in Drugs & Therapy Perspectives
    Article 09 July 2024
  5. Long-term topical corticosteroid treatment for atopic dermatitis: an in-depth analysis of safety, efficacy, withdrawal, and patient experiences

    Atopic dermatitis, often referred to as eczema, is classified as a chronic inflammatory skin disorder with increasing prevalence. Topical...

    Alyssa Ingurgio in Drugs & Therapy Perspectives
    Article 09 July 2024
  6. Uncovering the unique characteristics of different groups of 5-HT5AR ligands with reference to their interaction with the target protein

    Background

    The serotonin 5-HT 5A receptor has attracted much more research attention, due to the therapeutic potential of its ligands being...

    Szymon K. Kordylewski, Ryszard Bugno, ... Sabina Podlewska in Pharmacological Reports
    Article Open access 06 July 2024
  7. Corticosteroids are still first-line therapies for bullous pemphigoid, with biologics finding use in difficult-to-treat disease

    Bullous pemphigoid is an autoantibody-mediated subepidermal blistering disorder which develops predominately in patients of advanced age....

    Article 05 July 2024
  8. Advances in the anti-tumor mechanisms of saikosaponin D

    Saikosaponin D, a saponin compound, is extracted from Bupleurum and is a principal active component of the plant. It boasts a variety of...

    Ruixue Jia, Dandan Meng, Wei Geng in Pharmacological Reports
    Article 04 July 2024
  9. Efficiency of eSource Direct Data Capture in Investigator-Initiated Clinical Trials in Oncology

    Background

    Clinical trials have become larger and more complex. Thus, eSource should be used to enhance efficiency. This study aimed to evaluate the...

    Hiroko Yaegashi, Yukikazu Hayashi, ... Takuhiro Yamaguchi in Therapeutic Innovation & Regulatory Science
    Article Open access 02 July 2024
  10. Research progress of propofol in alleviating cerebral ischemia/reperfusion injury

    Ischemic stroke is a leading cause of adult disability and death worldwide. The primary treatment for cerebral ischemia patients is to restore blood...

    Hai**g Zheng, **an **ao, ... **nghua Zhao in Pharmacological Reports
    Article 02 July 2024
  11. Adis summary of research: Matching‑adjusted indirect comparisons of diroximel fumarate, ponesimod, and teriflunomide for relapsing multiple sclerosis

    Several oral disease-modifying therapies (DMTs) have been approved for the treatment of relapsing multiple sclerosis (MS), including diroximel...

    Hannah A. Blair in Drugs & Therapy Perspectives
    Article 01 July 2024
  12. Mutagenic Azido Impurities in Drug Substances: A Perspective

    Contamination of drug products and substances containing impurities is a significant concern in the pharmaceutical industry because it may impact the...

    Sumit S. Chourasiya, Deepika Kathuria, ... Kamlesh J. Ranbhan in Therapeutic Innovation & Regulatory Science
    Article 01 July 2024
  13. Can probiotics be used in the prevention and treatment of bronchial asthma?

    Asthma is a lifelong condition with varying degrees of severity and susceptibility to symptom control. Recent studies have examined the effects of...

    Paulina Kleniewska, Rafał Pawliczak in Pharmacological Reports
    Article Open access 01 July 2024
  14. Interactions between metabotropic glutamate and CB1 receptors: implications for mood, cognition, and synaptic signaling based on data from mGluR and CB1R-targeting drugs

    Metabotropic glutamate receptors (mGluRs) are part of the G protein-coupled receptors (GPCRs) family. They are coupled to G αq (group I) or G i/o ...

    Katarzyna Stachowicz in Pharmacological Reports
    Article Open access 28 June 2024
  15. Mechanistic insights on TLR-4 mediated inflammatory pathway in neurodegenerative diseases

    Neurodegenerative diseases (NDDs) pose a significant issue in healthcare, needing a thorough knowledge of their complex molecular mechanisms. A...

    Veerta Sharma, Prateek Sharma, Thakur Gurjeet Singh in Pharmacological Reports
    Article 25 June 2024
  16. A derivative of 3-(1,3-diarylallylidene)oxindoles inhibits dextran sulfate sodium-induced colitis in mice

    Background

    IA-0130 is a derivative of 3-(1,3-diarylallylidene)oxindoles, which is a selective estrogen receptor modulator (SERM). A previous study...

    Young-** Jeong, Hae-Ri Lee, ... Tae-Hwe Heo in Pharmacological Reports
    Article Open access 25 June 2024
  17. Qualitative Analysis of Inquiries Received by FDA Regarding Conduct of Clinical Trials during the Covid-19 Public Health Emergency

    Background

    This report describes the U.S. Food and Drug Administration (FDA) experience in establishing a dedicated mailbox, and in publishing related...

    Marijo Kambere, Hong Vu, ... John Concato in Therapeutic Innovation & Regulatory Science
    Article Open access 24 June 2024
  18. Multi-layered metabolic effects of trehalose on the liver proteome in apoE-knockout mice model of liver steatosis

    Background

    Metabolic dysfunction-associated fatty liver disease has been well documented as a key independent risk factor for the development of...

    Weronika Pogoda, Jakub Koczur, ... Maciej Suski in Pharmacological Reports
    Article Open access 24 June 2024
  19. Use of Seamless Study Designs in Oncology Clinical Development– A Survey Conducted by IDSWG Oncology Sub-team

    Seamless study designs have the potential to accelerate clinical development. The use of innovative seamless designs has been increasing in the...

    Yingwen Dong, Gautier Paux, ... Philip He in Therapeutic Innovation & Regulatory Science
    Article 22 June 2024
Did you find what you were looking for? Share feedback.